{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:25:22Z","timestamp":1772778322159,"version":"3.50.1"},"reference-count":44,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2017.5253","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T07:50:19Z","timestamp":1507017019000},"source":"Crossref","is-referenced-by-count":11,"title":["Suppression of Alzheimer's disease\u2011related phenotypes by the heat shock protein 70 inducer, geranylgeranylacetone, in APP\/PS1 transgenic mice via the ERK\/p38 MAPK signaling pathway"],"prefix":"10.3892","author":[{"given":"Yuan","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Geratology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang\u2011Rong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geratology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Geratology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"key20200713142713_b1-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/archneur.1976.00500040001001","article-title":"The prevalence and malignancy of Alzheimer disease: A Major Killer","volume":"33","author":"Katzman","year":"2008","journal-title":"Arch Neurol"},{"key":"key20200713142713_b2-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer's disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Dement"},{"key":"key20200713142713_b3-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"key20200713142713_b4-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"key20200713142713_b5-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(12)70200-4","article-title":"Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: A case-control study","volume":"11","author":"Whitwell","year":"2012","journal-title":"Lancet Neurol"},{"key":"key20200713142713_b6-etm-0-0-5253","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.3233\/JAD-2011-102139","article-title":"Amyloid clearance as a treatment target against Alzheimer's disease","volume":"24","author":"Kurz","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"key20200713142713_b7-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20200713142713_b8-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0896-6273(04)00533-1","article-title":"Clearance of Alzheimer's A\u03b2 Peptide: The Many Roads to Perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"key20200713142713_b9-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","article-title":"Mechanisms of amyloid-\u03b2 peptide clearance: Potential therapeutic targets for Alzheimer's disease","volume":"20","author":"Yoon","year":"2012","journal-title":"Biomol Ther (Seoul)"},{"key":"key20200713142713_b10-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","article-title":"Clearing amyloid through the blood-brain barrier","volume":"89","author":"Zlokovic","year":"2004","journal-title":"J Neurochem"},{"key":"key20200713142713_b11-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","article-title":"The role of inflammation in Alzheimer's disease","volume":"37","author":"Tuppo","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"key20200713142713_b12-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat Cell Biol"},{"key":"key20200713142713_b13-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0197-4580(02)00076-3","article-title":"Protein misfolding in Alzheimer's and Parkinson's disease: Genetics and molecular mechanisms","volume":"23","author":"Forloni","year":"2002","journal-title":"Neurobiol Aging"},{"key":"key20200713142713_b14-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/sj.emboj.7601970","article-title":"Chaperones in control of protein disaggregation","volume":"27","author":"Liberek","year":"2008","journal-title":"EMBO J"},{"key":"key20200713142713_b15-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/02656730500041871","article-title":"Role of molecular chaperones in neurodegenerative disorders","volume":"21","author":"Meriin","year":"2009","journal-title":"Int J Hyperthermia"},{"key":"key20200713142713_b16-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-0-387-39954-6_7","article-title":"The role of heat shock proteins during neurodegeneration in Alzheimer's, Parkinson's and Huntington's Disease","author":"Wyttenbach","year":"2009","journal-title":"Heat Shock Proteins in Neural Cells"},{"key":"key20200713142713_b17-etm-0-0-5253","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3233\/JAD-130779","article-title":"Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer's disease","volume":"38","author":"Bobkova","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"key20200713142713_b18-etm-0-0-5253","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JAD-2012-121534","article-title":"Low endogenous and chemical induced heat shock protein induction in a 0N3Rtau-expressing drosophila larval model of Alzheimer's disease","volume":"33","author":"Sinadinos","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"key20200713142713_b19-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1523\/JNEUROSCI.5478-10.2011","article-title":"Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice","volume":"31","author":"Hoshino","year":"2011","journal-title":"J Neurosci"},{"key":"key20200713142713_b20-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainres.2005.10.045","article-title":"Geranylgeranylacetone, a heat shock protein inducer, prevents acoustic injury in the guinea pig","volume":"1065","author":"Mikuriya","year":"2005","journal-title":"Brain Res"},{"key":"key20200713142713_b21-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: Evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum Mol Genet"},{"key":"key20200713142713_b22-etm-0-0-5253","unstructured":"KatsunoMSangCHAdachiHMinamiyamaMWazaMTanakaFDoyuMSobueGPharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron diseaseProc Natl Acad Sci USA1021680116806200510.1073\/pnas.050624910216260738"},{"key":"key20200713142713_b23-etm-0-0-5253","first-page":"e2920","article-title":"Morris water maze test for learning and memory deficits in Alzheimer's disease model mice","author":"Bromley-Brits","year":"2011","journal-title":"J Vis Exp: pii"},{"key":"key20200713142713_b24-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.neubiorev.2004.06.006","article-title":"The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory","volume":"28","author":"Hughes","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"key20200713142713_b25-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1101\/lm.1650110","article-title":"Object recognition memory and the rodent hippocampus","volume":"17","author":"Broadbent","year":"2009","journal-title":"Learn Mem"},{"key":"key20200713142713_b26-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1523\/JNEUROSCI.4792-03.2004","article-title":"Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain","volume":"24","author":"Iwata","year":"2004","journal-title":"J Neurosci"},{"key":"key20200713142713_b27-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","article-title":"Targeting p38 MAPK pathway for the treatment of Alzheimer's disease","volume":"58","author":"Munoz","year":"2010","journal-title":"Neuropharmacology"},{"key":"key20200713142713_b28-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3109\/02656730903315823","article-title":"Heat shock proteins in neurodegenerative diseases: Pathogenic roles and therapeutic implications","volume":"25","author":"Adachi","year":"2009","journal-title":"Int J Hyperthermia"},{"key":"key20200713142713_b29-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"e76306","DOI":"10.1371\/journal.pone.0076306","article-title":"Suppression of Alzheimer's disease-related phenotypes by geranylgeranylacetone in mice","volume":"8","author":"Hoshino","year":"2013","journal-title":"PLoS One"},{"key":"key20200713142713_b30-etm-0-0-5253","first-page":"287","article-title":"Role of mucus in gastric mucosal injury induced by local ischemia\/reperfusion","volume":"126","author":"Seno","year":"1995","journal-title":"J Lab Clin Med"},{"key":"key20200713142713_b31-etm-0-0-5253","first-page":"799","article-title":"Antiulcer effect of geranylgeranylacetone, a new acyclic polyisoprenoid on experimentally induced gastric and duodenal ulcers in rats","volume":"31","author":"Murakami","year":"1981","journal-title":"Arzneimittelforschung"},{"key":"key20200713142713_b32-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol"},{"key":"key20200713142713_b33-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"SYMPOSIUM: Clearance of A\u03b2 from the brain in Alzheimer's disease: Perivascular drainage of amyloid-\u03b2 peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol"},{"key":"key20200713142713_b34-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/156720507780362254","article-title":"Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: A position paper","volume":"4","author":"Finch","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"key20200713142713_b35-etm-0-0-5253","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.72.2.233","article-title":"Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease","volume":"72","author":"Griffin","year":"2002","journal-title":"J Leukoc Biol"},{"key":"key20200713142713_b36-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresrev.2008.07.003","article-title":"Association between the interleukin-1beta polymorphisms and Alzheimer's disease: A systematic review and meta-analysis","volume":"59","author":"Bona","year":"2008","journal-title":"Brain Res Rev"},{"key":"key20200713142713_b37-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2174\/138161208784705487","article-title":"The role of the cell Surface LRP and Soluble LRP in blood-brain barrier abeta clearance in Alzheimer's disease","volume":"14","author":"Deane","year":"2008","journal-title":"Curr Pharm Des"},{"key":"key20200713142713_b38-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/BF01923458","article-title":"Protective effects of the hsp70 in inflammation","volume":"50","author":"Jacquier-Sarlin","year":"1994","journal-title":"Experimentia"},{"key":"key20200713142713_b39-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.nbd.2008.12.014","article-title":"JNK regulates APP cleavage and degradation in a model of Alzheimer's disease","volume":"33","author":"Colombo","year":"2013","journal-title":"Neurobiol Dis"},{"key":"key20200713142713_b40-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/jnr.20380","article-title":"Mitogen- and stress-activated protein kinase 1: Convergence of the ERK and p38 pathways in Alzheimer's disease","volume":"79","author":"Webber","year":"2005","journal-title":"J Neurosci Res"},{"key":"key20200713142713_b41-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","article-title":"ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions","volume":"68","author":"Roux","year":"2004","journal-title":"Microbiol Mol Biol Rev"},{"key":"key20200713142713_b42-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.brainres.2012.10.059","article-title":"Induction of neurite outgrowth in PC12 cells by artemisinin through activation of ERK and p38 MAPK signaling pathways","volume":"1490","author":"Sarina","year":"2013","journal-title":"Brain Res"},{"key":"key20200713142713_b43-etm-0-0-5253","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","article-title":"Targeting p38 MAPK pathway for the treatment of Alzheimer's disease","volume":"58","author":"Lenka","year":"2010","journal-title":"Neuropharmacology"},{"key":"key20200713142713_b44-etm-0-0-5253","article-title":"Alzheimer's disease-specific alterations of the Erk1\/Erk2 phosphorylation ratio","author":"Khan","year":"2009","journal-title":"Journal"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T18:02:42Z","timestamp":1693072962000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.5253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":44,"URL":"https:\/\/doi.org\/10.3892\/etm.2017.5253","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,3]]}}}